New drug therapy for myeloma
Intended for healthcare professionals
Clinical update Previous     Next

New drug therapy for myeloma

Daniel Allen Freelance health writer

Essential facts

Myeloma, a cancer that develops from plasma cells in the bone marrow, is diagnosed in approximately 5,500 people in the UK each year. In 2014 it was the reason given for nearly 3,000 deaths. Cancer Research UK statistics show that about one third of patients with myeloma survive for ten years or more.

Cancer Nursing Practice. 17, 2, 11-11. doi: 10.7748/cnp.17.2.11.s8

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more